Hutch News

Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Hutch NewsJune 04, 2012
Change in PSA level may not predict prostate cancer

Change in PSA level may not predict prostate cancer

Center statistical analyses show screening for PSA velocity can lead to unnecessary biopsies
Hutch NewsMarch 14, 2011